Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
Open Access
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 8 (4) , 661-669
- https://doi.org/10.1074/mcp.m800313-mcp200
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discoveryJournal of Translational Medicine, 2008
- Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular DomainsPLOS ONE, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative BiomarkersJournal of Proteome Research, 2007
- Neutrophil gelatinase‐associated lipocalin (NGAL) an early‐screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor‐induced epithelio‐mesenchymal transitionInternational Journal of Cancer, 2007
- Diagnosis and Management of Epithelial Ovarian CancerObstetrics & Gynecology, 2006
- Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factorGynecologic Oncology, 2005
- Development of an Immunofluorometric Assay and Quantification of Human Kallikrein 7 in Tissue Extracts and Biological FluidsClinical Chemistry, 2004
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Epitopes on CA 125 from Cervical Mucus and Ascites Fluid and Characterization of Six New AntibodiesTumor Biology, 2002